Investigation of the Potential of Combined PPAR Alpha Agonists and AKR1C3 Inhibitors in pro Apoptotic Therapy of B Cell Malignancies

Project Details

Short titleInvestigation of the Potential of Combined PPAR Alpha Agonists and AKR1C3 Inhibitors in pro Apoptotic Therapy of B Cell Malignancies
StatusFinished
Effective start/end date1/10/029/11/05

Funding

  • BLOODWISE